GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OSTO:RAY B) » Definitions » EV-to-EBIT

RaySearch Laboratories AB (OSTO:RAY B) EV-to-EBIT : 34.82 (As of Jun. 18, 2024)


View and export this data going back to 1991. Start your Free Trial

What is RaySearch Laboratories AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, RaySearch Laboratories AB's Enterprise Value is kr4,940 Mil. RaySearch Laboratories AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr142 Mil. Therefore, RaySearch Laboratories AB's EV-to-EBIT for today is 34.82.

The historical rank and industry rank for RaySearch Laboratories AB's EV-to-EBIT or its related term are showing as below:

OSTO:RAY B' s EV-to-EBIT Range Over the Past 10 Years
Min: -4052.82   Med: 35.68   Max: 8801.93
Current: 34.82

During the past 13 years, the highest EV-to-EBIT of RaySearch Laboratories AB was 8801.93. The lowest was -4052.82. And the median was 35.68.

OSTO:RAY B's EV-to-EBIT is ranked worse than
80.14% of 433 companies
in the Healthcare Providers & Services industry
Industry Median: 17.24 vs OSTO:RAY B: 34.82

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. RaySearch Laboratories AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr4,028 Mil. RaySearch Laboratories AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr142 Mil. RaySearch Laboratories AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 3.52%.


RaySearch Laboratories AB EV-to-EBIT Historical Data

The historical data trend for RaySearch Laboratories AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB EV-to-EBIT Chart

RaySearch Laboratories AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.82 -3,596.87 -45.52 62.17 27.40

RaySearch Laboratories AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.43 32.33 32.94 27.40 28.39

Competitive Comparison of RaySearch Laboratories AB's EV-to-EBIT

For the Health Information Services subindustry, RaySearch Laboratories AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's EV-to-EBIT falls into.



RaySearch Laboratories AB EV-to-EBIT Calculation

RaySearch Laboratories AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4939.850/141.867
=34.82

RaySearch Laboratories AB's current Enterprise Value is kr4,940 Mil.
RaySearch Laboratories AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr142 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RaySearch Laboratories AB  (OSTO:RAY B) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

RaySearch Laboratories AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=141.867/4027.931
=3.52 %

RaySearch Laboratories AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr4,028 Mil.
RaySearch Laboratories AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr142 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RaySearch Laboratories AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


RaySearch Laboratories AB (OSTO:RAY B) Business Description

Traded in Other Exchanges
Address
Sveavagen 44, P.O. Box 3297, Stockholm, SWE, 103 65
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.

RaySearch Laboratories AB (OSTO:RAY B) Headlines

No Headlines